On Thursday, results were released from a preliminary study indicating that the Pfizer vaccine against COVID-19 may successfully fight off variant forms of the virus that have been discovered in Great Britain and South Africa. The study has not yet been peer-reviewed.
Researchers from the University of Texas Medical Branch in Galveston joined with Pfizer to examine how the Pfizer vaccine countered the variant viruses, some of which which share a mutation called N501Y that alters the spike protein coating the virus, thus rendering it more contagious.
“They used blood samples from 20 people who received the vaccine, made by Pfizer and its German partner BioNTech, during a large study of the shots,” AP reported. “Antibodies from those vaccine recipients successfully fended off the virus in lab dishes, according to the study posted late Thursday on an online site for researchers.”
The study states:
Since the previously reported studies were conducted, rapidly spreading variants of SARS-CoV-2 have arisen in the United Kingdom